Global Tissue Heart Valves Market 2016-2020

  • ID: 3623620
  • Report
  • Region: Global
  • 41 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Braile Biomédica
  • CryoLife
  • Edwards Lifesciences
  • Labcor Laboratórios
  • LivaNova
  • Medtronic
  • MORE
About Tissue Heart Valves

Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues.

Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

The analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors:

- Edwards Lifesciences
- LivaNova
- Medtronic
- St. Jude Medical

Other prominent vendors:

- Braile Biomédica
- CryoLife
- Labcor Laboratórios

Market drivers

- Demand for stentless tissue valves
- For a full, detailed list, view the full report

Market challenges

- Lack of skilled personnel
- For a full, detailed list, view the full report

Market trends

- Increase in M&A
- For a full, detailed list, view the full report

Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Braile Biomédica
  • CryoLife
  • Edwards Lifesciences
  • Labcor Laboratórios
  • LivaNova
  • Medtronic
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Cost analysis
  • Cost analysis of valve replacement procedures
PART 07: Market segmentation by product

PART 08: Geographical segmentation
  • Tissue heart valves market in Americas
  • Tissue heart valves market in EMEA
  • Tissue heart valves market in APAC
PART 09: Market drivers
  • Prevalence of heart valve diseases
  • Demand for stentless tissue valves
  • Implementation of MI procedures
  • Rise in geriatric population
PART 10: Impact of drivers

PART 11: Market challenges
  • Use of alternative products
  • Risk of potential complications
  • Lack of skilled personnel
  • Stringent regulatory framework
PART 12: Impact of drivers and challenges

PART 13: Market trends
  • Demand for tissue heart valves in APAC
  • Preference among geriatric population
  • Increase in M&A
PART 14: Vendor landscape
  • Competitive scenario
  • Market share analysis 2015
  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
PART 16: About Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global tissue heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global tissue heart valves market segmentation by product
Exhibit 06: Global tissue heart valves market segmentation by product 2015
Exhibit 07: Global tissue heart valves market segmentation by geography 2015
Exhibit 08: Global tissue heart valves market segmentation by geography 2020
Exhibit 09: Global tissue heart valves market segmentation by geography 2015-2020
Exhibit 10: Tissue heart valves market in Americas 2015-2020 ($ millions)
Exhibit 11: Tissue heart valves market in US 2015-2020 ($ millions)
Exhibit 12: Tissue heart valves market in EMEA 2015-2020 ($ millions)
Exhibit 13: Tissue heart valves market in APAC 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Cost comparison of heart valve replacement procedures
Exhibit 17: Ranking of top vendors 2015
Exhibit 18: Edwards Lifesciences: Key takeaways
Exhibit 19: LivaNova: Key takeaways
Exhibit 20: Medtronic: Key product offerings
Exhibit 21: Medtronic: Key takeaways
Exhibit 22: St. Jude Medical: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Braile Biomédica
  • CryoLife
  • Edwards Lifesciences
  • Labcor Laboratórios
  • LivaNova
  • Medtronic
  • MORE
New Report Released: – Global Tissue Heart Valves Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Tissue Heart Valves Market: Edwards Lifesciences, LivaNova, Medtronic and St. Jude Medical

Other Prominent Vendors in the market are: Braile Biomédica, CryoLife and Labcor Laboratórios

Commenting on the report, an analyst from the research team said: “Vendors undergo M&A to extend their product offerings, increase their market shares, and expand their operations. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. Acquisition of other companies allows vendors access to the product portfolio of the acquired company. M&A as a business strategy helps new players enter the market.”

According to the report, demand for stentless tissue valves is driving the market growth during the forecast period. Physicians prefer stentless tissue valves as they have a wider valve opening. This allows the blood to flow more freely similar to a normal, healthy valve. The tissue stentless tissue heart valves are flexible. This flexibility along with a wider valve opening helps the blood to avoid a damaged stent in the heart and flow uniformly.

Further, the report states that Lack of skilled personnel is hindering the market growth. The number of interventional cardiologists in medical facilities, such as hospitals and clinics worldwide, is low. Moreover, the technical expertise of medical professionals in local medical facilities is not up to par with those in well-known facilities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Edwards Lifesciences
- LivaNova
- Medtronic
- St. Jude Medical
- Braile Biomédica
- CryoLife
- Labcor Laboratórios
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll